Life Sciences | IHS Blogs

KEY TAKEAWAYS: Customers are returning to the US market, with 16.5 million vehicle sales expected in 2025. EV sales in the US crossed the one-million mark for the first time in 2023, but EV growt...

http://www.spglobal.com/mobility/en/research-analysis/us-ev-sales-grew-nearly-52-in-2023.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/esg-permeates-pharmaceutical-pricing-strategy.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/reimbursement-outcomes-combination-therapies-breast-cancer.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/us-announces-support-of-covid19-vaccine-ip-waiver.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/how-to-democratize-access-prevent-next-supermodel-medicine.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/united-states-experience-dramatic-shift-public-healthcare.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/norwegian-pharma-industry-calls-for-tendering-and-irp-reforms.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/greek-pharma-industry-unites-against-growing-burden-of-clawback.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/an-all-encompassing-market-access-strategy-in-africa.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/impact-of-the-tianjin-explosion-on-the-global-pharmaceutical-industry.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/when-do-price-changes-occur-for-branded-pharmaceuticals-in-the-top-5-eu-markets.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/repatha-versus-praluent-will-the-approval-of-pcsk9-inhibitors-trigger-a-new-price-war-in-the-us.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/the-economics-of-ebola-vaccine-production.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/therapeutic-positioning-reports-in-spain-more-doubts-and-questions.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/the-war-against-superbugs-intensifies.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/nice-eschews-value-based-assessment-for-now-are-we-ready-for-consensus.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/ukraines-current-healthcare-market-uncertainty-pricing-reforms-and-calls-for-the-health-ministers-resignation.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/flexible-pricing-in-the-uk-where-is-industry.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/how-much-weight-do-canadas-hta-assessments-carry-and-could-value-based-tiered-formularies-gain-traction-in-the-us-some-thoughts-from-ispor.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/pharma-adjusts-to-patent-expiries-price-cuts-and-pipeline-setbacks-is-a-mega-merger-frenzy-returning.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/polands-reimbursement-act-a-promise-only-partially-delivered.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/statins-controversy-in-the-us-what-do-the-new-cholesterol-guidelines-mean.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/market-access-process-in-france-what-is-changing.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/is-a-mexican-nice-on-the-cards.html

Industry insights from the IHS Life Sciences team covering market access, pricing and reimbursement, emerging markets, generics strategies, therapeutic development pathways, forecasting and market sizing, and general competitive intelligence.

http://www.spglobal.com/research-analysis/pharmaceutical-price-cuts-in-south-korea-in-2013.html